J&J Says Chmp Recommends Approval Of Talvey Combo In Earlier Line Treatment Of R/R Multiple Myeloma RTT News 13:21 Fri, 16 Oct
Adverse family outcomes reported for children with B-cell all Psychiatry Advisor 5d Leukaemia Cancer Cancer Treatment All sources
CAR T-cell therapy delivers durable responses in r/r MCL, other lymphomas Rare Disease Advisor 3d T-Cells Cancer Treatment Cancer All sources
The Wildhearts frontman Ginger Wildheart, 61, marries partner Jane Graley seven months after being diagnosed with terminal cancer MailOnline 12:03 Thu, 15 Oct Celeb News Article paywall
Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule PR Newswire (Press Release) 7h
The international myeloma foundation launches US myeloma network to accelerate clinical trials, expand access, and improve patient care PR Newswire (Press Release) 3d IMF US Economy
Johnson & Johnson reports first real-world varipulse pro platform data and 12-month omnypulse platform outcomes for atrial fibrillation treatment at aphrs 2026 Business Wire (Press Release) 3d
Johnson & Johnson announces new data showing Tremfya® (guselkumab) is the only IL-23 to deliver durable fistula remission through 48 weeks in Crohn's disease with perianal fistula PR Newswire (Press Release) 6d Inflammatory Bowel Disease
Nearly one third of patients with advanced melanoma saw tumors disappear completely after receiving TIL therapy plus pembrolizumab immunotherapy News-Medical.Net 1d Cancer Cancer Treatment Science
Beyond chemotherapy: 2 pharma stocks betting on the next wave of cancer treatment The Financial Express 2d India Indian Politics
FDA launches Rare Disease Framework Initiative, seeks public input Rare Disease Advisor 2d FDA Rare Diseases Science
